Aevi raises $28M in private placement

On Oct. 17, genetic disease company Aevi Genomic Medicine Inc. (NASDAQ:GNMX) raised $28 million through the sale of 22.2 million shares at $1.26 in a private placement led by the Children’s Hospital of Philadelphia Foundation. Investors also received warrants to purchase up to 4 million shares...